Hypertension


Figure 13.1 – Blood pressure measurement.



Hypertension In A Heartbeat




















Epidemiology


Affects around a third of patients aged 45–54 and around 60–80% of patients aged 75 and over.


Aetiology


90% of cases are ‘essential’. ‘Secondary’ hypertension can be attributed to renal and endocrine causes, as well as pregnancy, aortic coarctation and a variety of medications.


Clinical features


Usually asymptomatic. Clinical signs such as Cushingoid features, renal bruits and weak/delayed femoral pulses may indicate a secondary cause of hypertension.


Investigations


If clinic blood pressure is greater than 140/90, offer ambulatory blood pressure monitoring. Assess target organ damage and cardiovascular risk in patients with confirmed hypertension. Patients with blood pressure greater than 180/110 should be managed immediately


Management


Step 1: A (or C if >55 or Afro-Caribbean)
Step 2: A+C
Step 3: A+C+D
Step 4: consider further diuretic therapy, alpha-blockers or beta-blockers
(A = ACE inhibitor/angiotensin receptor blocker; C = calcium channel blocker; D = thiazide-like diuretic)


13.1.1 Definition


Blood pressure (BP) and cardiovascular disease risk have a continuous relationship, so it is impossible to precisely define hypertension. However, for practical purposes, hypertension is when arterial blood pressure reaches levels which significantly increase cardiovascular risk; and when treatment can provide a clear-cut benefit. Hypertension is usually diagnosed by measuring the average BP from multiple readings. This will be explained further below. A consistently high BP over 140/90 is considered as hypertension.


13.1.2 Epidemiology



  • 31% of males and 28% of females over the age of 35 have, or are being treated for hypertension.
  • This prevalence increases with age:

    • in those aged 45–54 years: 33% of males, 25% of females
    • in those aged >75 years: 66% males, 78% females

GUIDELINES: Diagnosis of hypertension (NICE, 2011)


NICE employs the following definitions in its guidelines:


Stage 1 hypertension:


Clinic blood pressure (CBP) = 140/90 mmHg or higher, and


Ambulatory blood pressure monitoring (ABPM) average or home blood pressure monitoring (HBPM) average = 135/85 mmHg or higher


Stage 2 hypertension:


CBP = 160/100 mmHg or higher, and


ABPM/HBPM average = 150/95 or higher


Severe hypertension:


Clinic systolic blood pressure = 180 mmHg or higher, or


Clinic diastolic blood pressure = 110 mmHg or higher


13.1.3 Aetiology


95% of cases are classified as ‘essential’ – i.e. the underlying cause has not been identified. The other 5% of causes are classified as ‘secondary’, which can be due to the following:



  • Renal disease

    • diabetic nephropathy, renovascular disease, glomerulonephritis, vasculitides, chronic pyelonephritis, polycystic kidneys

  • Endocrine disease

    • Conn’s and Cushing’s syndromes, glucocorticoid remediable hypertension, phaeochromocytoma, acromegaly, hyperparathyroidism

  • Other

    • aortic coarctation, pregnancy-induced hypertension and pre-eclampsia, obesity, excessive dietary salt, drugs (e.g. NSAIDs, sympathomimetics, illicit stimulants such as amphetamine, MDMA, and cocaine).

13.1.4 Pathophysiology


Normal blood pressure regulation


There are four main physiological mechanisms in the human body which regulate blood pressure:



  • Cardiac contractility and pumping pressure
  • Blood vessel tone and systemic resistance
  • Intravascular volume regulation, controlled by the kidneys
  • Hormones – which control the other three mechanisms (refer to Chapter 1)

These mechanisms form the process of ‘pressure natriuresis’ in normal functioning kidneys.


Blood pressure regulation in hypertensive patients


An increase in BP leads to an increase in urine production and sodium excretion, in an attempt to reduce intravascular volume and return arterial pressure to normal. Pressure natriuresis is less efficacious in hypertensive patients because of:



  • Microvascular and tubulointerstitial kidney damage due to hypertension
  • Defects in hormonal regulation of blood pressure such as the renin–angiotensin system (refer to Chapter 1).

    • hormonal regulation anomalies are the target of a host of antihypertensive medications, including ACE inhibitors and diuretics (refer to Chapter 5).


// PRO-TIP //


Baroreceptors are not involved in the regulation of chronic hypertension as they constantly ‘reset’ themselves, usually after 24–48 hours of high blood pressure. For more information about blood pressure regulation, refer to Chapter 1.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Apr 3, 2017 | Posted by in CARDIOLOGY | Comments Off on Hypertension

Full access? Get Clinical Tree

Get Clinical Tree app for offline access